Beijing Cerebro Pharmaceutical Technology

Beijing Cerebro Pharmaceutical Technology is a China-based biotechnology company focused on the research and development of innovative therapeutics for central nervous system (CNS) disorders. The company primarily targets neurodegenerative conditions such as Alzheimer's disease and vascular dementia, as well as acute conditions like ischemic stroke. Their research efforts are centered on identifying novel small molecules and peptide-based drugs that can cross the blood-brain barrier to modulate key pathological pathways. Beijing Cerebro aims to address significant unmet medical needs in the aging population through its specialized focus on neuropharmacology.